GlassScriptPhysician profile
Amy R Lindquist
NPI 1275733107
$5,858.25
in general payments reported to CMS, 2019-2025
30 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $541 · 2022: $1,135 · 2023: $1,420 · 2024: $1,296 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,181.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,681.58 | 2021-2025 | Leqvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $435.37 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $399.85 | 2021-2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $309.56 | 2021-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $293.50 | 2021-2025 | Verquvo |
| Abiomed | $225.66 | 2024-2025 | Impella |
| Alnylam Pharmaceuticals INC. | $223.03 | 2022-2023 | Amvuttra |
| Pfizer INC. | $218.39 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.39 | 2021-2025 | Lifevest |
| Esperion Therapeutics, INC. | $209.75 | 2021-2025 | Nexletol |
| Boston Scientific Corporation | $194.42 | 2022-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $190.50 | 2021-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $179.17 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $154.90 | 2023-2025 | |
| Shockwave Medical, INC | $147.14 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $120.91 | 2024-2025 | Ozempic |
| Amgen INC. | $119.39 | 2023-2025 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $86.26 | 2025 | |
| Abbott Laboratories | $74.92 | 2024-2025 | Aveir, Amplatzer Amulet, Cardiomems |
| Kiniksa Pharmaceuticals International, Plc | $70.55 | 2024 | Arcalyst |
| Medtronic, INC. | $57.23 | 2025 | Aurora Ev-Icd Mri Surescan |
| Daiichi Sankyo INC. | $52.78 | 2022-2023 | Injectafer |
| Sanofi-Aventis U.S. LLC | $42.71 | 2024 | |
| Cvrx, INC. | $37.28 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $28.97 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $23.90 | 2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $18.49 | 2023 | Evkeeza |
| Arbor Pharmaceuticals, INC. | $17.21 | 2021 | |
| Amarin Pharma, INC. | $15.35 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lindquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.